Decoding Gene Therapy: Redefining Health, Longevity and Regenerative Medicine

Welcome to a riveting episode where we venture into the future of medicine with Elizabeth Parrish, the CEO of BioViva, a vanguard in the gene therapy revolution.  Today, we'll unveil the mysteries of gene therapy, explore its profound implications for enhancing health and longevity, and hear firsthand from Elizabeth about her own gene therapy journey.  With BioViva's innovative approach, we're peering into a world where reversing the clock on cellular aging isn't just a possibility—it's the beginning of a new era in combating age-related diseases.    We talk about: 07:10 - Transitioning to gene therapy and starting BioViva 12:30 - The impact of increasing health span on the planet and using restorative medicine 19:00 - When is someone sick and when is someone in good health 28:00 - Elizabeth's personal experience with gene therapy and her results 38:00 - The lack of movement in the field of gene therapy 42:00 - Accessing gene therapies through medical tourism 47:00 - Medical tourism: available countries and costs 53:00 - Candidates for longevity: epigenetics and cell regulators   Sponsors: Visit InsideTracker to get your vitamins, hormones and minerals tested, and enter code BIOHACKINGBRITTANY to get 20% off all plans! Fatty15 has 3X more cellular benefits than omega-3 and reverses the core of how we age. Enhance your healthspan and boost your everyday cellular function with Mimio daily cell care. Use BIOHACKINGBRITTANY at checkout to save.      Resources: Try my Hormone Balancing Chocolate recipe! It's delicious and your body and hormones will thank you. My Ebb and Flow Cycle Guide solves all your hormone problems! Download it now for all the answers on cycle syncing and hormone balancing.  Enter my giveaway for a free women's health consultation on my website! Visit BioViva's website Let's Connect: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, Google Podcasts

There are no comments yet.

Please log in to write the first comment.